127 related articles for article (PubMed ID: 12636170)
21. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.
Bangalore R; Baindur N; Rutledge A; Triggle DJ; Kass RS
Mol Pharmacol; 1994 Oct; 46(4):660-6. PubMed ID: 7969044
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.
Mak IT; Zhang J; Weglicki WB
Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858
[TBL] [Abstract][Full Text] [Related]
23. Actions of 1,4-dihydropyridines in isolated mesenteric vascular beds.
Dhein S; Zhao Y; Simsek S; Salameh A; Klaus W
J Cardiovasc Pharmacol; 1995 Nov; 26(5):784-91. PubMed ID: 8637194
[TBL] [Abstract][Full Text] [Related]
24. Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells.
Lob H; Rosenkranz AC; Breitenbach T; Berkels R; Drummond G; Roesen R
Pharmacology; 2006; 76(1):8-18. PubMed ID: 16220025
[TBL] [Abstract][Full Text] [Related]
25. Photophysics and photochemical studies of 1,4-dihydropyridine derivatives.
Pávez P; Encinas MV
Photochem Photobiol; 2007; 83(3):722-9. PubMed ID: 17132066
[TBL] [Abstract][Full Text] [Related]
26. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
27. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
28. The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state.
Naskrent M; Mielcarek J
Spectrochim Acta A Mol Biomol Spectrosc; 2007 May; 67(1):251-5. PubMed ID: 16987696
[TBL] [Abstract][Full Text] [Related]
29. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
Soldatov NM
Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
[TBL] [Abstract][Full Text] [Related]
30. The effect of photogenerated site-directed free radicals on surface dihydropyridine binding sites identified with photoaffinity probe (-)-[3H]-azidopine on cultured monkey renal cells.
Drímal J; Bohácik L
Methods Find Exp Clin Pharmacol; 1994; 16(6):397-404. PubMed ID: 7530790
[TBL] [Abstract][Full Text] [Related]
31. Effect of tunable redox behavior of bis chelate substituted 1,10-phenantroline Cu(II) complexes on its reaction with superoxide anion in DMSO. Toward a simple criterion to identify a SOD-like mechanism.
Manzanera-Estrada ME; Cruz-Ramírez M; Flores-Alamo M; Gracia Y Jiménez JM; Galindo-Murillo R; García-Ramos JC; Ruiz-Azuara L; Ortiz-Frade L
J Inorg Biochem; 2017 Oct; 175():118-128. PubMed ID: 28753490
[TBL] [Abstract][Full Text] [Related]
32. [Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications].
Wachowiak R; Strach B; Lopatka P
Arch Med Sadowej Kryminol; 2005; 55(1):47-54. PubMed ID: 15984121
[TBL] [Abstract][Full Text] [Related]
33. Structural effects on the reactivity 1,4-dihydropyridines with alkylperoxyl radicals and ABTS radical cation.
Yáñez C; López-Alarcón C; Camargo C; Valenzuela V; Squella JA; Núñez-Vergara LJ
Bioorg Med Chem; 2004 May; 12(9):2459-68. PubMed ID: 15080941
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant activity of 4-flavonil-1,4-dihydropyridine derivatives.
Kruk I; Kladna A; Lichszteld K; Michalska T; Aboul-Enein HY; Tunçbilek M; Ertan R
Biopolymers; 2001; 62(3):163-7. PubMed ID: 11343286
[TBL] [Abstract][Full Text] [Related]
35. Nitro radical anion formation from nitrofuryl substituted 1,4-dihydropyridine derivatives in mixed and non-aqueous media.
Argüello J; Núñez-Vergara LJ; Bollo S; Squella JA
Bioelectrochemistry; 2006 Sep; 69(1):104-12. PubMed ID: 16473565
[TBL] [Abstract][Full Text] [Related]
36. Elucidating the pre- and post-nuclear intracellular processing of 1,4-dihydropyridine based gene delivery carriers.
Hyvönen Z; Hämäläinen V; Ruponen M; Lucas B; Rejman J; Vercauteren D; Demeester J; De Smedt S; Braeckmans K
J Control Release; 2012 Aug; 162(1):167-75. PubMed ID: 22709591
[TBL] [Abstract][Full Text] [Related]
37. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier.
Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
Eur J Pharmacol; 2011 Jun; 659(2-3):124-9. PubMed ID: 21497592
[TBL] [Abstract][Full Text] [Related]
38. Oxidative activation of dihydropyridine amides to reactive acyl donors.
Funder ED; Trads JB; Gothelf KV
Org Biomol Chem; 2015 Jan; 13(1):185-98. PubMed ID: 25358438
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo characterization of 2,6-dimethyl-3,5-dicarbomethoxy-4-(2-isothiocyano)phenyl-1,4- dihydropy ridine as a Ca2+ channel antagonist.
Gengo P; Su CM; Yousif FB; Triggle DJ
Can J Physiol Pharmacol; 1987 Dec; 65(12):2472-82. PubMed ID: 3449204
[TBL] [Abstract][Full Text] [Related]
40. Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.
Ravera M; Baracco S; Cassino C; Zanello P; Osella D
Dalton Trans; 2004 Aug; (15):2347-51. PubMed ID: 15278129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
